Discover open access scientific publications

Search, annotate, share and cite publications

Publications by P Hillmen

Extended Follow-Up and Impact of High-Risk Prognostic Factors From the Phase 3 RESONATE Study in Patients With Previously Treated CLL/SLL

Leukemia

English

Flow Cytometric Protein Expression Profiling as a Systematic Approach for Developing Disease-Specific Assays: Identification of a Chronic Lymphocytic Leukaemia-Specific Assay for Use in Rituximab-Containing Regimens

English

Related publications

Patterns of Duvelisib-Induced Lymphocytosis in Patients With R/R CLL or SLL Including Those With High-Risk Factors Treated in the Duo Trial

Hematological Oncology

English

Ibrutinib Versus Temsirolimus: 3-Year Follow-Up of Patients With Previously Treated Mantle Cell Lymphoma From the Phase 3, International, Randomized, Open-Label RAY Study

English

Long-Term Follow-Up of the RESONATE™ Phase 3 Trial of Ibrutinib Versus Ofatumumab

English

Predictors of Sudden Cardiac Death in Never Previously Treated Patients With Essential Hypertension: Long-Term Follow-Up

Journal of Human Hypertension

Internal Medicine

2001

English

Extended Follow-Up of Treated and Untreated Retinopathy in Incontinentia Pigmenti

JAMA Ophthalmology

Ophthalmology

2015

English

Risk Factors for Fall in Elderly Patients: Follow-Up Study After Hospital Discharge

Open Journal of Internal Medicine

2018

English

Prognostic Factors for Patients Treated With Abiraterone

English

Risk for High Depressive Symptoms in Diagnosed and Previously Undetected Diabetes: 5-Year Follow-Up Results of the Heinz Nixdorf Recall Study

PLoS ONE

Multidisciplinary

2013

English

Atezolizumab in Japanese Patients With Previously Treated, Advanced Non–small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by P Hillmen

Extended Follow-Up and Impact of High-Risk Prognostic Factors From the Phase 3 RESONATE Study in Patients With Previously Treated CLL/SLL

Flow Cytometric Protein Expression Profiling as a Systematic Approach for Developing Disease-Specific Assays: Identification of a Chronic Lymphocytic Leukaemia-Specific Assay for Use in Rituximab-Containing Regimens

Related publications

Patterns of Duvelisib-Induced Lymphocytosis in Patients With R/R CLL or SLL Including Those With High-Risk Factors Treated in the Duo Trial

Ibrutinib Versus Temsirolimus: 3-Year Follow-Up of Patients With Previously Treated Mantle Cell Lymphoma From the Phase 3, International, Randomized, Open-Label RAY Study

Long-Term Follow-Up of the RESONATE™ Phase 3 Trial of Ibrutinib Versus Ofatumumab

Predictors of Sudden Cardiac Death in Never Previously Treated Patients With Essential Hypertension: Long-Term Follow-Up

Extended Follow-Up of Treated and Untreated Retinopathy in Incontinentia Pigmenti

Risk Factors for Fall in Elderly Patients: Follow-Up Study After Hospital Discharge

Prognostic Factors for Patients Treated With Abiraterone

Risk for High Depressive Symptoms in Diagnosed and Previously Undetected Diabetes: 5-Year Follow-Up Results of the Heinz Nixdorf Recall Study

Atezolizumab in Japanese Patients With Previously Treated, Advanced Non–small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study